Skip to content
TrialScanner

NCT06879067

Safety, Tolerability and Immune Effects of the Nasal Foralumab in Healthy Human Volunteers

Phase 1CompletedTLSALead

Registry record

Lead sponsor
Tiziana Life Sciences LTD
Conditions
Safety; Tolerability
Primary completion
Jul 23, 2019Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT06879067 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.